Negocios · 1/5/20141 min de lectura
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Expedited Programs for Serious Conditions-Drugs and Biologics
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Guidance for Industry on Expedited Programs for Serious Conditions--Drugs and Biologics" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.